These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 9406725

  • 1. Dosimetry of fractionated experimental radioimmunotargeting with idiotypic and anti-idiotypic anticytokeratin antibodies.
    Rossi Norrlund R, Ullén A, Sandström P, Holback D, Johansson L, Stigbrand T, Hietala SO, Riklund Ahlström K.
    Cancer; 1997 Dec 15; 80(12 Suppl):2681-8. PubMed ID: 9406725
    [Abstract] [Full Text] [Related]

  • 2. Experimental radioimmunotargeting combining nonlabeled, iodine-125-labeled, and anti-idiotypic anticytokeratin monoclonal antibodies: a dosimetric evaluation.
    Rossi Norrlund R, Ullén A, Sandström P, Holback D, Johansson L, Stigbrand T, Hietala SO, Riklund Ahlström K.
    Cancer; 1997 Dec 15; 80(12 Suppl):2689-98. PubMed ID: 9406726
    [Abstract] [Full Text] [Related]

  • 3. Dosimetry of fractionated administration of 125I-labeled antibody at experimental radioimmunotargeting.
    Ullén A, Sandström P, Rossi Norrlund R, Rathsman S, Johansson L, Riklund Ahlström K, Hietala SO, Stigbrand T.
    Cancer; 1997 Dec 15; 80(12 Suppl):2510-8. PubMed ID: 9406704
    [Abstract] [Full Text] [Related]

  • 4. Combinations of nonlabeled, 125I-labeled, and anti-idiotypic antiplacental alkaline phosphatase monoclonal antibodies at experimental radioimmunotargeting.
    Rossi Norrlund R, Holback D, Johansson L, Hietala SO, Ahlström KR.
    Acta Radiol; 1997 Nov 15; 38(6):1087-93. PubMed ID: 9394676
    [Abstract] [Full Text] [Related]

  • 5. Use of anticytokeratin monoclonal anti-idiotypic antibodies to improve tumor:nontumor ratio in experimental radioimmunolocalization.
    Ullén A, Sandström P, Ahlström KR, Sundström B, Nilsson B, Arlestig L, Stigbrand T.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5868s-5873s. PubMed ID: 7493362
    [Abstract] [Full Text] [Related]

  • 6. The combination of external beam radiotherapy and experimental radioimmunotargeting with a monoclonal anticytokeratin antibody.
    Johansson A, Eriksson D, Ullén A, Löfroth PO, Johansson L, Riklund-Ahlström K, Stigbrand T.
    Cancer; 2002 Feb 15; 94(4 Suppl):1314-9. PubMed ID: 11877762
    [Abstract] [Full Text] [Related]

  • 7. Localization of complexed anticytokeratin 8 scFv TS1-218 to HeLa HEp-2 multicellular tumor spheroids and experimental tumors.
    Jafari R, Holm P, Sandegren J, Stigbrand T, Sundström BE.
    Cancer Biother Radiopharm; 2010 Aug 15; 25(4):455-63. PubMed ID: 20707717
    [Abstract] [Full Text] [Related]

  • 8. Stability and immunoreactivity of the monoclonal anticytokeratin antibody TS1 after different degrees of iodination.
    Johansson A, Sandström P, Ullén A, Erlandsson A, Sundström B, Ahlström KR, Johansson L, Hietala SO, Stigbrand T.
    Acta Oncol; 1999 Aug 15; 38(3):329-34. PubMed ID: 10380824
    [Abstract] [Full Text] [Related]

  • 9. Studies of the interactions between the anticytokeratin 8 monoclonal antibody TS1, its antigen and its anti-idiotypic antibody alphaTS1.
    Erlandsson A, Holm P, Ullén A, Stigbrand T, Sundström BE.
    J Mol Recognit; 2003 Aug 15; 16(3):157-63. PubMed ID: 12833571
    [Abstract] [Full Text] [Related]

  • 10. Radioimmunoscintigraphy with a novel monoclonal antiprostate antibody (E4): an experimental study in nude mice.
    Rydh A, Riklund Ahlström K, Widmark A, Johansson L, Nilsson S, Bergh A, Damber JE, Stigbrand T, Hietala SO.
    Cancer; 1997 Dec 15; 80(12 Suppl):2398-403. PubMed ID: 9406689
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of growth of HeLa cell tumours in nude mice by 125I-labeled anticytokeratin and antiPLAP monoclonal antibodies.
    Riklund KE, Makiya R, Sundström B, Bäck O, Henriksson R, Hietala SO, Stigbrand T.
    Anticancer Res; 1991 Dec 15; 11(2):555-60. PubMed ID: 1712175
    [Abstract] [Full Text] [Related]

  • 12. Dosimetric comparison of bolus and continuous injections of CC49 monoclonal antibody in a colon cancer xenograft model.
    Roberson PL, Dudek S, Buchsbaum DJ.
    Cancer; 1997 Dec 15; 80(12 Suppl):2567-75. PubMed ID: 9406711
    [Abstract] [Full Text] [Related]

  • 13. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis.
    DeNardo GL, DeNardo SJ, Wessels BW, Kukis DL, Miyao N, Yuan A.
    Cancer Biother Radiopharm; 2000 Dec 15; 15(6):547-60. PubMed ID: 11190487
    [Abstract] [Full Text] [Related]

  • 14. Syngeneic anti-idiotypic antibodies eliminate excess radiolabeled idiotypes at experimental radioimmunolocalization.
    Ullén A, Riklund Ahlström K, Makiya R, Stigbrand T.
    Cell Biophys; 1995 Aug 15; 27(1):31-45. PubMed ID: 7493397
    [Abstract] [Full Text] [Related]

  • 15. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ, Khazaeli MB, Mayo MS, Roberson PL.
    Clin Cancer Res; 1999 Oct 15; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [Abstract] [Full Text] [Related]

  • 16. In vivo clearing of idiotypic antibodies with antiidiotypic antibodies and their derivatives.
    Erlandsson A, Eriksson D, Johansson L, Riklund K, Stigbrand T, Sundström BE.
    Mol Immunol; 2006 Feb 15; 43(6):599-606. PubMed ID: 15978666
    [Abstract] [Full Text] [Related]

  • 17. Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent hapten.
    Hosono M, Hosono MN, Kraeber-Bodéré F, Devys A, Thédrez P, Fiche M, Gautherot E, Barbet J, Chatal JF.
    J Nucl Med; 1998 Sep 15; 39(9):1608-13. PubMed ID: 9744353
    [Abstract] [Full Text] [Related]

  • 18. Idiotypic-anti-idiotypic complexes and their in vivo metabolism.
    Johansson A, Erlandsson A, Eriksson D, Ullén A, Holm P, Sundström BE, Roux KH, Stigbrand T.
    Cancer; 2002 Feb 15; 94(4 Suppl):1306-13. PubMed ID: 11877761
    [Abstract] [Full Text] [Related]

  • 19. Radioimmunoscintigraphy using an anti-prostate monoclonal antibody (E4): a dosimetric evaluation.
    Rydh A, Riklund Ahlström K, Widmark A, Johansson L, Nilsson S, Bergh A, Damber JE, Stigbrand T, Hietala SO.
    Urol Res; 2001 Jun 15; 29(3):216-20. PubMed ID: 11482450
    [Abstract] [Full Text] [Related]

  • 20. Variations in radioimmunoscintigraphic detection of tumor showed by five monoclonal antibodies to carcinoembryonic antigen.
    Kohno K, Nakata K, Kusumoto Y, Ishii N, Kohji T, Matsuoka Y, Nishi S, Nagataki S.
    Ann Nucl Med; 1991 Jul 15; 5(2):69-75. PubMed ID: 1777353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.